(Q42262369)

English

Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study

scientific article published on 11 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Coexistence of hepatitis B surface antigen and antibody to hepatitis B surface may increase the risk of hepatocellular carcinoma in chronic hepatitis B virus infection: a retrospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

Hepatitis B virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

author name string

Seung In Seo

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hyeok Soo Choi

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Bo Youn Choi

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hyoung Su Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hak Yang Kim

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Myoung Kuk Jang

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

11 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Journal of Medical Virology

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

86

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

124-130

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hepatitis B and C virus hepatocarcinogenesis: lessons learned and future challenges.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Natural history of chronic hepatitis B REVEALed

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Co-occurrence of HBsAg and anti-HBs: Two consecutive infections or a sign of advanced chronic liver disease?

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

PreS deletion mutations of hepatitis B virus in chronically infected patients with simultaneous seropositivity for hepatitis-B surface antigen and anti-HBS antibodies.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Comparison of nine commercially available assays for quantification of antibody response to hepatitis B virus surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Role of viral factors in the natural course and therapy of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

The underlying mechanisms for the "simultaneous HBsAg and anti-HBs serological profile".

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Pre-s mutation is a significant risk factor for hepatocellular carcinoma development: a long-term retrospective cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

A novel deletion mutant of hepatitis B virus surface antigen.

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Clinical and virological significance of the co-existence of HBsAg and anti-HBs antibodies in hepatitis B chronic carriers

1 reference

https://api.crossref.org/works/10.1002%2FJMV.23779

21 January 2018

Identifiers

10.1002/JMV.23779

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42262369&oldid=1940402579"